LegalCove
LegalCove
Active Lawsuit

Baby Formula NEC Lawsuit

Your premature infant was fed Similac or Enfamil and later diagnosed with necrotizing enterocolitis (NEC)? You may be eligible for substantial compensation. Get a free case review.

$60M

In Settlements

100K+

Cases Filed/Pending

Active

Lawsuit Status

$0

Upfront Cost

Key Takeaways

Linked Injuries

Necrotizing enterocolitis, intestinal perforation, sepsis, organ damage, death

Product

Similac and Enfamil infant formula

Companies

Mead Johnson, Abbott Nutrition

Status

MDL 1:22-cv-00071 (N.D. Illinois) - Bellwether trials scheduled 2026-2027

About Baby Formula NEC Lawsuit

Similac and Enfamil infant formula products have been linked to necrotizing enterocolitis (NEC), a life-threatening gastrointestinal condition that disproportionately affects premature infants fed with cow-milk-based formulas. NEC occurs when bacteria penetrate the intestinal lining, causing inflammation and tissue death. This devastating condition can develop suddenly in vulnerable infants and may result in permanent organ damage, long-term complications, or death.

Scientific studies have demonstrated that premature infants, particularly those born before 32 weeks gestational age, face significantly elevated risk of developing NEC when fed cow-milk-based formula products. The lawsuits allege that formula manufacturers failed to warn about this increased NEC risk in vulnerable populations and failed to implement adequate safety warnings despite knowledge of the connection.

With recent state court verdicts ranging from $60 million to $495 million, the cases demonstrate the serious harm caused by this defective formula. If your premature infant was fed Similac or Enfamil and subsequently developed NEC, you may be eligible for significant compensation to cover medical expenses, ongoing care, and pain and suffering.

Health Risks & Effects

Exposure to this product has been linked to serious health conditions and injuries. Research and case settlements have documented the following health risks:

Necrotizing enterocolitis (NEC) - inflammatory bowel necrosis
Intestinal perforation and bowel rupture
Sepsis and bacterial infection
Chronic gastrointestinal complications
Permanent organ damage requiring surgical intervention
Death in severe cases

Do I Qualify for This Lawsuit?

You may be eligible to file a claim if you meet the following criteria. Each case is unique, and a qualified attorney can provide a definitive assessment during a free case review.

Premature Birth

Your infant was born prematurely, typically before 32 weeks gestational age, making them vulnerable to NEC.

Formula Feeding

Your infant was fed Similac or Enfamil formula, documented through medical records or purchase receipts.

NEC Diagnosis

Your infant was diagnosed with necrotizing enterocolitis between 2011 and the present, with medical documentation of the diagnosis.

No Prior Settlement

You have not already accepted a settlement or signed a release with formula manufacturers related to NEC claims.

Important: Family members who lost a loved one may also be eligible to file a wrongful death claim. A free case review can help determine your specific options and eligibility.

Settlements & Verdicts

Recent settlements and verdicts demonstrate the significant compensation available to qualified claimants:

March 2024

Illinois State Court Verdict

$60 million verdict in state court, establishing significant compensation precedent.

July 2024

Missouri State Court Verdict

$495 million verdict in state court, one of the largest infant formula settlements to date.

2024-Present

Individual Settlement Ranges

Individual settlements ranging from $45,000 to $600,000 depending on case severity and medical outcomes.

Settlement amounts vary based on individual circumstances, medical severity, and liability factors. Consult with a qualified attorney for personalized settlement estimates.

Lawsuit Timeline

The litigation timeline shows how this lawsuit has developed from initial complaints through current settlement discussions:

2022

MDL 1:22-cv-00071 established in Northern District of Illinois

March 2024

Illinois state court verdict of $60 million

July 2024

Missouri state court verdict of $495 million

February 2026

Bellwether trial scheduled (Inman v. Mead Johnson)

August 2026

Additional bellwether trials scheduled

2026-2027

Further bellwether trials and potential MDL-wide settlement negotiations

How to File a Claim

Filing a claim is a straightforward process designed to minimize hassle while maximizing your recovery potential:

1

Get a Case Review

Contact LegalCove and answer brief questions about your exposure and medical condition. Your information remains completely confidential.

2

Speak with an Attorney

If you qualify, a legal advocate will contact you to discuss your situation and explain your options.

3

Get Matched

We connect you with an experienced attorney who specializes in this litigation — at no upfront cost.

Frequently Asked Questions

Settlement discussions are ongoing. A global MDL settlement is anticipated, though not yet finalized. Bellwether trials will establish precedent for settlement ranges.
Based on recent state verdicts, settlement ranges from $45,000-$600,000 depending on medical complexity and outcome. Individual amounts vary significantly.
Yes, medical causation must be established through expert testimony and medical records showing the connection between formula feeding and NEC development.
775 cases are pending in federal court as of February 2026. Bellwether trials scheduled for 2026-2027 will establish legal and factual precedent.